It was a prospective, randomized clinical trial undertaken to evaluate whether finasteride (5 mg/day) significantly reduced the period prevalence of prostate cancer in initially healthy men ...

The 24.8% relative risk reduction in prostate cancer seen in the finasteride arm prompted the early termination of the study on February 21, 2003, 15 months before its anticipated completion.

The 5 mg regimen reduces serum PSA levels, and guidelines currently recommend that PSA values of men who undergo prostate-cancer screening while taking 5 mg finasteride daily should be doubled ...

Molecular studies of the PCPT...should allow personalized prevention of prostate cancer with finasteride Uniquely, the PCPT was designed to ascertain its primary endpoint (detection of prostate ...

DEAR DR. ROACH: I read in a health journal that large amounts of sodium are unhealthy for one’s diet. The government standard ...

Finasteride has been shown to lower the overall risk of prostate cancer. However, some old research from 1993 suggested it might increase the risk of high-grade prostate cancer. These earlier ...

Finasteride has been shown to lower the overall risk of prostate cancer. However, some old research from 1993 suggested it might increase the risk of high-grade prostate cancer. These earlier ...

Get detailed information on Finasteride, including pronunciation ... prescribed for benign prostatic hyperplasia (BPH), prostate cancer, and hair loss. It prevents testosterone conversion in ...

The risk of prostate cancer is no greater for men with an enlarged ... the muscles of the prostate and bladder dutasteride and finasteride - alpha-reductase inhibitors that stop the prostate ...

Although finasteride may lower overall prostate cancer risk for men, some research suggests that it may be associated with an increased risk of high-grade prostate cancer in older men. Overall ...